Business
US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News
The US Food and Drug Administration approves Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and…
The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.
- The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
- However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
- Remdesivir will be sold…
Continue Reading
-
Noosa News10 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General19 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News24 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
General20 hours agoSharp rise in airfares push UK inflation higher in July